These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 17889130

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil.
    Doria C, Ramirez CB, Frank AM, Vaccino S, Fraser N, Marino IR.
    Clin Transplant; 2009; 23(6):882-6. PubMed ID: 19573090
    [Abstract] [Full Text] [Related]

  • 23. Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation.
    Rath T, Küpper M.
    Transplant Proc; 2009; 41(6):2524-8. PubMed ID: 19715967
    [Abstract] [Full Text] [Related]

  • 24. Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.
    Sollinger H.
    Transplant Proc; 2004 Mar; 36(2 Suppl):517S-520S. PubMed ID: 15041399
    [Abstract] [Full Text] [Related]

  • 25. Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).
    Budde K, Knoll G, Curtis J, Chan L, Pohanka E, Gentil M, Seifu Y, Marrast AC, Neumayer HH, ERL B302 Study Group.
    Clin Nephrol; 2006 Aug; 66(2):103-11. PubMed ID: 16939066
    [Abstract] [Full Text] [Related]

  • 26. Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study.
    Abbud-Filho M, Girón F, Hernández E, Juarez F, Liendo C, Novoa P, Toledo M, Myproms Latam Study Group.
    Transplant Proc; 2004 Aug; 36(6):1647-9. PubMed ID: 15350440
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G, Burke GW, Gaynor JJ, Roth D, Sageshima J, Kupin W, Tueros L, Hanson L, Rosen A, Ruiz P, Miller J.
    Transplantation; 2008 Jul 15; 86(1):67-74. PubMed ID: 18622280
    [Abstract] [Full Text] [Related]

  • 30. Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients.
    Toledo AH, Hendrix L, Buchholz V, Fisher E, Newton K, Smith C, Gerber DA.
    Clin Transplant; 2012 Jul 15; 26(1):156-63. PubMed ID: 21470310
    [Abstract] [Full Text] [Related]

  • 31. Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients.
    Burg M, Säemann MD, Wieser C, Kramer S, Fischer W, Lhotta K.
    Transplant Proc; 2009 Dec 15; 41(10):4159-64. PubMed ID: 20005359
    [Abstract] [Full Text] [Related]

  • 32. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
    Langone A, Shihab F, Pankewycz O, Doria C, Wiland A, McCague K, Chan L.
    Clin Transplant; 2014 Sep 15; 28(9):961-7. PubMed ID: 24893821
    [Abstract] [Full Text] [Related]

  • 33. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies.
    Pietruck F, Abbud-Filho M, Vathsala A, Massari PU, Po-Huang L, Nashan B.
    Transplant Proc; 2007 Sep 15; 39(1):103-8. PubMed ID: 17275484
    [Abstract] [Full Text] [Related]

  • 34. Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.
    Bunnapradist S, Sampaio MS, Wilkinson AH, Pham PT, Huang E, Kuo HT, Anastasi B, Danovitch GM, Lo SK.
    Am J Nephrol; 2014 Sep 15; 40(2):184-90. PubMed ID: 25196230
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.
    Tedesco-Silva H, Bastien MC, Choi L, Felipe C, Campestrini J, Picard F, Schmouder R.
    Transplant Proc; 2005 Mar 15; 37(2):852-5. PubMed ID: 15848554
    [Abstract] [Full Text] [Related]

  • 36. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.
    Arns W, Breuer S, Choudhury S, Taccard G, Lee J, Binder V, Roettele J, Schmouder R.
    Clin Transplant; 2005 Apr 15; 19(2):199-206. PubMed ID: 15740555
    [Abstract] [Full Text] [Related]

  • 37. The impact of conversion from mycophenolate mofetil to mycophenolate sodium among renal transplant recipients on a sirolimus-based regimen.
    Kahan BD, Podbielski J, Childs B.
    Transplant Proc; 2008 Jun 15; 40(5):1429-34. PubMed ID: 18589123
    [Abstract] [Full Text] [Related]

  • 38. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
    Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N, ERL2401 Heart Study Investigators.
    J Heart Lung Transplant; 2006 Aug 15; 25(8):935-41. PubMed ID: 16890114
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.
    Budde K, Knoll G, Curtis J, Kahana L, Pohanka E, Seifu Y, Neumayer HH.
    Transplant Proc; 2005 Mar 15; 37(2):912-5. PubMed ID: 15848573
    [Abstract] [Full Text] [Related]

  • 40. Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil.
    Lopez-Solis R, DeVera M, Steel J, Fedorek S, Sturdevant M, Hughes C, Humar A.
    Clin Transplant; 2014 Jul 15; 28(7):783-8. PubMed ID: 24754682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.